Astera Labs (ALAB) CEO-linked trust sells 123,750 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Astera Labs, Inc. reported that a living trust associated with Chief Executive Officer Mohan Jitendra sold 123,750 shares of Common Stock in open-market transactions. The trust sold 99,023 shares at a weighted average price of $149.5322 per share and 24,727 shares at a weighted average price of $150.2535 per share.
The filing states these sales occurred automatically under a Rule 10b5-1 trading plan adopted on December 1, 2025. After the sales, the living trust reported holding 4,407,982 shares indirectly, and the filing also lists additional indirect holdings in several estate planning trusts and 1,452,739 shares held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 123,750 shares ($18,522,445)
Net Sell
8 txns
Insider
Mohan Jitendra
Role
Chief Executive Officer
Sold
123,750 shs ($18.52M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 99,023 | $149.5322 | $14.81M |
| Sale | Common Stock | 24,727 | $150.2535 | $3.72M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 4,432,709 shares (Indirect, By Living Trust);
Common Stock — 1,452,739 shares (Direct)
Footnotes (1)
- The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.0000 to $149.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.0000 to $150.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Key Figures
Shares sold (block 1): 99,023 shares at $149.5322
Shares sold (block 2): 24,727 shares at $150.2535
Total shares sold: 123,750 shares
+4 more
7 metrics
Shares sold (block 1)
99,023 shares at $149.5322
Open-market sale on April 10, 2026 by living trust
Shares sold (block 2)
24,727 shares at $150.2535
Second open-market sale on April 10, 2026 by living trust
Total shares sold
123,750 shares
Aggregate net-sell reported in transaction summary
Living trust holdings after trades
4,407,982 shares
Indirect Common Stock ownership following April 10, 2026 sales
Direct holdings
1,452,739 shares
Common Stock held directly as of April 10, 2026
2021 Trust 1 holdings
700,000 shares
Indirect Common Stock ownership by 2021 Trust 1
2022 Trust 1 holdings
450,001 shares
Indirect Common Stock ownership by 2022 Trust 1
Key Terms
Rule 10b5-1 trading plan, weighted average price, beneficial ownership, estate planning trust, +1 more
5 terms
Rule 10b5-1 trading plan financial
"The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
estate planning trust financial
"These shares are owned directly by an estate planning trust (the "Trust")."
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What insider transaction did Astera Labs (ALAB) disclose for Mohan Jitendra?
Astera Labs disclosed that a living trust associated with CEO Mohan Jitendra sold 123,750 Common Stock shares. The trust executed open-market sales of 99,023 shares at $149.5322 and 24,727 shares at $150.2535 per share on April 10, 2026.
Were the Astera Labs (ALAB) insider sales by Mohan Jitendra pre-planned?
Yes. The sales were executed under a pre-arranged Rule 10b5-1 trading plan. The filing notes the plan was adopted on December 1, 2025, meaning the trades occurred automatically according to preset instructions rather than day-to-day market timing decisions.
What price range did the Astera Labs (ALAB) insider sales cover on April 10, 2026?
The reported weighted average prices were $149.5322 and $150.2535 per share. Footnotes explain that actual trades occurred in multiple transactions within ranges of $149.00 to $149.99 and $150.00 to $150.63, with full details available upon request to the company or regulators.